Global Health Limited, which conducts and supervises Medanta hospitals, will unveil its initial public offering (IPO) on November 3, 2022. The issue will conclude on November 7, 2022, according to the red herring prospectus (RHP).
The IPO will consist of a new issue of equity shares aggregating to Rs 500 crore and an offer-for-sale (OFS) of up to 5.08 crore equity shares. Anant Investments, an affiliate of private equity major Carlyle Group, and Sunil Sachdeva (jointly with Suman Sachdeva) would offload equity shares, as a part of the OFS.
Currently, Anant Investments bears a 25.64 per cent stake in Global Health and Sachdeva holds a 13.41 per cent stake in the company.
Global Health, backed by private equity investors such as Carlyle Group and Temasek, uses a network of five hospitals under the Medanta brand in Gurugram, Indore, Ranchi, Lucknow, and Patna.
Additionally, one hospital is under construction in Noida. The company’s total installed beds are expected to exceed 3,500 upon its operation of Noida hospital in fiscal 2025.
The company reported a total income of Rs 2,205.8 crore and a profit of Rs 196.2 crore in FY22. The Indian healthcare delivery industry is estimated to post a 13-15 per cent CAGR between FY21 and FY26, driven by pent-up demand, strong fundamentals, increasing affordability, and Ayushman Bharat Yojana, according to a Crisil report.